Acadian Asset Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-93,305
| Closed | -$15K | – | 2089 |
|
|
2019
Q2 | $15K | Sell |
93,305
-174,600
| -65% | -$28.1K | ﹤0.01% | 1620 |
|
|
2019
Q1 | $53K | Buy |
267,905
+248,476
| +1,279% | +$49.2K | ﹤0.01% | 1658 |
|
|
2018
Q4 | $14K | Hold |
19,429
| – | – | ﹤0.01% | 1588 |
|
|
2018
Q3 | $24K | Hold |
19,429
| – | – | ﹤0.01% | 1493 |
|
|
2018
Q2 | $22K | Buy |
+19,429
| New | +$22K | ﹤0.01% | 1521 |
|
|
2015
Q3 | – | Sell |
-711
| Closed | -$4K | – | 1503 |
|
|
2015
Q2 | $4K | Buy |
+711
| New | +$4K | ﹤0.01% | 1295 |
|